Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
作者信息
McCarroll Kevin, Fitzpatrick Donal, Lannon Rosaleen
机构信息
Bone Health Unit, Mercer's Institute for Successful Ageing, St James's Hospital, Dublin, Ireland.
School of Medicine, Trinity College Dublin, Dublin, Ireland.
出版信息
Osteoporos Int. 2024 Oct;35(10):1869-1870. doi: 10.1007/s00198-024-07218-x. Epub 2024 Aug 9.
PMID:39120626
Abstract
摘要
相似文献
1
Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
Osteoporos Int. 2024 Oct;35(10):1869-1870. doi: 10.1007/s00198-024-07218-x. Epub 2024 Aug 9.
2
Author response to: OSIN-D-24-00849 Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
Osteoporos Int. 2024 Oct;35(10):1871-1872. doi: 10.1007/s00198-024-07214-1. Epub 2024 Aug 9.
3
A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
Osteoporos Int. 2024 Sep;35(9):1669-1675. doi: 10.1007/s00198-024-07139-9. Epub 2024 Jun 5.
4
Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab.
Osteoporos Int. 2019 Dec;30(12):2437-2448. doi: 10.1007/s00198-019-05146-9. Epub 2019 Oct 18.
5
Denosumab after 8 years.
Osteoporos Int. 2015 Dec;26(12):2759-61. doi: 10.1007/s00198-015-3347-z. Epub 2015 Oct 16.
6
[Sequential drug treatments for osteoporosis].
Rev Med Suisse. 2025 Apr 16;21(914):783-787. doi: 10.53738/REVMED.2025.21.914.47112.
7
Cancel the denosumab holiday.
Osteoporos Int. 2016 May;27(5):1677-82. doi: 10.1007/s00198-016-3553-3. Epub 2016 Mar 1.
8
Treatment of glucocorticoid-induced osteoporosis with concurrent denosumab and romosozumab: a case report.
Osteoporos Int. 2024 Nov;35(11):2061-2068. doi: 10.1007/s00198-024-07243-w. Epub 2024 Sep 17.
9
Early administration of romosozumab prevents rebound of bone resorption related to denosumab withdrawal in fractured post-menopausal women: a real-world prospective study.
J Endocrinol Invest. 2025 May;48(5):1249-1256. doi: 10.1007/s40618-025-02542-3. Epub 2025 Jan 31.
10
Romosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials.
Osteoporos Int. 2024 Jul;35(7):1195-1204. doi: 10.1007/s00198-024-07049-w. Epub 2024 Apr 4.
Zotero 插件